Back to Results
First PageMeta Content
Biology / Medicine / Swedish Orphan Biovitrum / Biogen Idec / Factor VIII / Factor IX / Pfizer / Coagulation / Haemophilia / Coagulation system / Anatomy


ANNUAL REPORTWe’ve got a story to tell 1 The financial year in brief
Add to Reading List

Document Date: 2015-04-14 10:40:54

Open Document

File Size: 4,43 MB

Share Result on Facebook

City

Waltham / /

Company

SEK 308 M T / Auxilium Pharmaceuticals Inc. / Pfizer / Biogen / Sobi Sobi / /

Continent

North America / Europe / /

Country

Switzerland / Japan / Austria / United States / Canada / Australia / /

Currency

SEK / USD / /

Event

FDA Phase / Company Expansion / Business Partnership / Employment Change / /

Facility

Safe Harbor / /

IndustryTerm

treatment of Peyronie’s disease / haemophilia products / healthcare / medicinal products / materials or services / healthcare providers / therapies and services / /

MedicalCondition

rare diseases / Haemophilia / metastatic medullary thyroid carcinoma / Dupuytren’s contracture / Peyronie´s disease / haemophilia A / disease / rare disease / haemophilia B. Both / longer-acting haemophilia A / diseases / Peyronie’s disease / connective tissue deformity / Inflammation / /

MedicalTreatment

enzyme replacement therapy / innovative therapies / /

Organization

Committee for Medicinal Products for Human Use / World Federation of Hemophilia / European Medicines Agency / US Food and Drug Administration / EU Commission / European Union / /

Person

Geoffrey McDonough / Kirsti Gjellan / /

Position

CEO / STATEMENT CEO / CEO and President / Private / Senior Vice President Manufacturing Operations / /

Product

Orfadin / Kepivance / Kineret / SOBI002 / Canada / Japan / Eloctate® / Europe / Eloctate / /

ProvinceOrState

Massachusetts / /

RadioStation

10 Who / 22 What / /

Region

East Africa / Middle East / North Africa / /

Technology

2014 Health Technology / /

SocialTag